Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12012449 Human IL-23 antigen binding proteins

Patent 12012449 was granted and assigned to Amgen on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Jun, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 19 Jun, 2024
Edits made to:
Infobox (+59 properties)
Article (+283 characters)
‌

 US Patent 12012449 Human IL-23 antigen binding proteins

Article

Patent abstract

Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Amgen
Amgen
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120124490
Patent Inventor Names
Derek E. Piper0
Heather Cerne0
Janet D. Cheng0
Jason C. O'Neill0
Jennifer E. Towne0
Randal R. Ketchem0
Yu Sun0
Yu Zhang0
Date of Patent
June 18, 2024
0
Patent Application Number
175254210
Date Filed
November 12, 2021
0
Patent Citations
‌
US Patent 7090847 Mammalian cytokines; related reagents and methods
0
‌
US Patent 7247711 IL-23p40 specific antibody
0
‌
US Patent 7282204 Uses of IL-23 agonists and antagonists; related reagents
0
‌
US Patent 7491391 Anti-IL-23 antibodies, compositions, methods and uses
0
‌
US Patent 7501247 Method of treating skin inflammation
0
‌
US Patent 7504485 Human antibodies that bind human IL-12
0
‌
US Patent 7510709 Method of treating inflammatory disease by inhibition of IL-17 production
0
‌
US Patent 7575741 Methods of treating cutaneous ulcers and grafts using IL-23
0
‌
US Patent 7608690 IL-B30 antibodies
0
‌
US Patent 7700739 IL-12/p40 binding proteins
0
‌
US Patent 7740848 Method of treatment of skin inflammation
0
‌
US Patent 7750126 Antibodies that bind to a member of the IL-6/G-CSF/MGF family
0
‌
US Patent 7790862 IL-17 and IL-23 antagonists and methods of using the same
0
‌
US Patent 7807160 Engineered anti-IL-23 antibodies
0
‌
US Patent 7807414 Anti-IL-23 antibodies, compositions, methods and uses
0
‌
US Patent 7820168 Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
0
‌
US Patent 7872102 Anti-IL-23 antibodies
0
‌
US Patent 7883704 Methods for inhibiting the activity of the P40 subunit of human IL-12
0
‌
US Patent 7893215 Agonist antibodies to IL-23 receptor
0
‌
US Patent 7910703 Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
0
‌
US Patent 7935344 Human anti-IL-23 antibodies, compositions, methods and uses
0
‌
US Patent 7993645 Human anti-IL-23 antibodies, compositions, methods and uses
0
‌
US Patent 8080247 Anti-IL-12 antibodies
0
‌
US Patent 8106177 Nucleic acids encoding human anti-IL-23 antibodies
0
‌
US Patent 8110187 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto
0
‌
US Patent 8182810 IL-B30 antibodies
0
‌
US Patent 8221760 Methods of treatment using human anti-IL-23 antibodies
0
‌
US Patent 8227579 IL-23 antagonists
0
‌
US Patent 8287869 Method of treating inflammatory disease by inhibition of IL-17 production
0
‌
US Patent 8293883 Engineered anti-IL-23P19 antibodies
0
‌
US Patent 8329170 Method for treating psoriasis by administering an anti-IL-12 antibody
0
‌
US Patent 8333968 Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19
0
‌
US Patent 8362212 Engineered anti-IL-23 antibodies
0
‌
US Patent 8404813 Engineered anti-IL-23P19 antibodies
0
‌
US Patent 8563697 Anti-IL-12/IL-23 antibodies
0
‌
US Patent 8586035 Use of IL-23 antagonists for treatment of infection
0
‌
US Patent 8778346 Anti-IL-23 antibodies
0
‌
US Patent 8927693 Fibronectin based scaffold domain proteins that bind IL-23
0
‌
US Patent 11220541 CCL20 as a predictor of clinical response to IL23-antagonists
0
‌
US Patent 11016099 Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers
0
‌
US Patent 6914128 Human antibodies that bind human IL-12 and methods for producing
0
Patent Primary Examiner
‌
Prema M Mertz
0
CPC Code
‌
A61K 39/395
0

Find more entities like US Patent 12012449 Human IL-23 antigen binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo